title: Further information on the administration of h2-receptor antagonists with atazanavir.
authors.forename: Sangeeta
authors.initials: S
authors.lastname: Agarwala
authors.forename: Gary
authors.initials: G
authors.lastname: Thal
authors.forename: Richard
authors.initials: R
authors.lastname: Nettles
authors.forename: Richard
authors.initials: R
authors.lastname: Bertz
mesh_terms: D000069446:Atazanavir Sulfate; D004347:Drug Interactions; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D018023:HIV Seronegativity; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage*; D011725:Pyridines / Q000008:administration & dosage*
chemical_list: D017320:HIV Protease Inhibitors; D006635:Histamine H2 Antagonists; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate